|
TMEM183A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63149999954371E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.90610000005975E-07 |
| Normal-vs-Stage2 |
1.858470E-03 |
| Normal-vs-Stage3 |
1.92761999999735E-05 |
| Normal-vs-Stage4 |
3.420900E-03 |
| Stage1-vs-Stage2 |
7.328200E-01 |
| Stage1-vs-Stage3 |
8.877000E-01 |
| Stage1-vs-Stage4 |
5.637400E-01 |
| Stage2-vs-Stage3 |
7.176600E-01 |
| Stage2-vs-Stage4 |
8.726600E-01 |
| Stage3-vs-Stage4 |
5.831000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89040000320162E-08 |
| Normal-vs-AfricanAmerican |
5.874200E-01 |
| Normal-vs-Asian |
3.759200E-04 |
| Caucasian-vs-AfricanAmerican |
7.944000E-03 |
| Caucasian-vs-Asian |
2.627200E-01 |
| AfricanAmerican-vs-Asian |
9.218200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64127999999764E-05 |
| Normal-vs-Female |
2.44800000048784E-07 |
| Male-vs-Female |
8.731000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.91150000003771E-06 |
| Normal-vs-Age(41-60Yrs) |
6.50570000093609E-08 |
| Normal-vs-Age(61-80Yrs) |
1.421730E-03 |
| Normal-vs-Age(81-100Yrs) |
5.607200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.775000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.764000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.376600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.401590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.879430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.259800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.096650E-01 |
| Classical-VS-Follicular |
7.902400E-01 |
| Classical-VS-Other |
7.265000E-01 |
| Classical-VS-Normal |
2.34539999999228E-05 |
| Tall-VS-Follicular |
1.403820E-01 |
| Tall-VS-Other |
6.676600E-01 |
| Tall-VS-Normal |
1.77417999999152E-05 |
| Follicular-VS-Other |
7.375400E-01 |
| Follicular-VS-Normal |
1.939150E-03 |
| Other-VS-Normal |
2.514400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63976999999482E-05 |
| Normal-vs-N1 |
4.2506999997638E-07 |
| N0-vs-N1 |
4.644500E-02 |
|
|
